To determine the recommended dose of endoscopically assisted high-dose-rate intraluminal brachytherapy (HDR-192Ir-ILBT) as a palliative treatment of extrahepatic biliary tract cancer.
Mattiucci, G. C., Autorino, R., Tringali, A., Perri, V., Balducci, M., Deodato, F., Gambacorta, M. A., Mantini, G., Tagliaferri, L., Mutignani, M., Morganti, A., A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer, <<BRACHYTHERAPY>>, 2015; 14 (3): 401-404. [doi:10.1016/j.brachy.2014.12.002] [http://hdl.handle.net/10807/71232]
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer
Mattiucci, Gian Carlo;Tringali, Andrea;Perri, Vincenzo;Balducci, Mario;Deodato, Francesco;Gambacorta, Maria Antonietta;Mantini, Giovanna;
2015
Abstract
To determine the recommended dose of endoscopically assisted high-dose-rate intraluminal brachytherapy (HDR-192Ir-ILBT) as a palliative treatment of extrahepatic biliary tract cancer.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
